A study finds 70 years may be a key cutoff for oxaliplatin benefit in stage III colorectal cancer, with no survival advantage seen in older patients o...

Personalized expert instruction informed by artificial intelligence (AI) data improved surgical performance and skill transfer more effectively than A...

As the demand for mental health care grows, calls for restructuring what some consider a broken system are louder than ever, with overburdened provide...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, blee...

A new report from Bluesight reveals how automation and analytics are helping hospital pharmacy teams cut spending, manage shortages, and streamline pr...

Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucag...

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affec...

Bevacizumab combined with chemotherapy was not as effective in advanced driver gene-negative nonsquamous non–small cell lung cancer (NSCLC) compared w...

Robert F. Kennedy Jr halted 22 mRNA vaccine initiatives, drawing criticism from health experts over pandemic preparedness concerns.